Central Kentucky event turns women’s heart health into a local clinical priority
Cardiovascular disease remains the leading cause of death in women, yet awareness still lags behind the disease burden. In Lexington, the American Heart Association used its Go Red for Women movement to press that gap into the open, pairing community fundraising with a blunt message: women cannot afford to treat heart health as a distant concern. The Central Kentucky event drew more than 500 attendees and raised over $300,000 to support research, education, and advocacy aimed at better identifying, diagnosing, treating, and preventing cardiovascular disease in women.
The campaign’s language is deliberately direct. Red usually signals caution or a stop sign, but here it is used to push action. For women who still underestimate their own cardiovascular risk, that reversal matters. It is not only a branding exercise; it reflects a longstanding clinical problem in which symptoms are missed, risk is underappreciated, and care pathways are often slower to recognize women’s distinct presentations.
Why women’s cardiovascular risk still goes underrecognized
Nearly half of women age 20 and older are living with some form of cardiovascular disease. At the same time, less than half of women are aware that heart disease is their greatest health threat. Those two figures sit uneasily beside one another. The disconnect helps explain why prevention efforts remain difficult: patients cannot respond to a risk they do not believe applies to them.
Women also encounter biologic and life-stage factors that can shift cardiovascular risk across the lifespan. Pregnancy and menopause are not peripheral details; they are clinical inflection points that can alter blood pressure, vascular function, metabolic risk, and downstream cardiovascular vulnerability. A prevention strategy that ignores those transitions leaves major gaps in care. Women remain underrepresented in cardiovascular research as well, which means evidence often arrives without enough female-specific data to guide decisions with confidence.
One sentence captures the bedside consequence. Women are still less likely to receive CPR from a bystander.
That reality turns public education into more than a slogan. It is a survival issue.
Local fundraising tied to research, education, and advocacy
The Central Kentucky event honored survivors and celebrated progress in heart health, but its practical purpose was narrower and more urgent: to sustain work that closes persistent gaps in women’s cardiovascular care. The more than $300,000 raised will support efforts to improve the ways clinicians and communities identify and address risk in women. In a disease area where prevention hinges on blood pressure control, symptom recognition, lifestyle counseling, and timely treatment, community support can influence access to the tools that matter most.
The local message from organizers was grounded in that reality. Kristen Goble Brown, Central Kentucky Go Red for Women co-chair and community volunteer, framed the event as an education and awareness effort that helps women understand their risks and how to reduce them. Shannon Nally, the other co-chair and market director for philanthropy with Saint Joseph Health Foundations, tied the work to access: better education and life-saving care for women “at every age and stage of life.” Those statements fit the clinical mandate. Risk reduction is not abstract when a disease remains the leading killer of women.
The event also reflected a broader strategic point about prevention. Awareness campaigns have limited value if they do not lead to action: blood pressure screening, lipid management, smoking cessation, diabetes control, exercise, nutrition, and prompt evaluation of concerning symptoms. Women need more than reassurance. They need a system that recognizes their risk early and responds before disease becomes advanced or irreversible.
Pregnancy, menopause, and the need for women-specific cardiovascular care
Pregnancy and menopause create windows during which cardiovascular risk can shift, sometimes subtly and sometimes dramatically. A woman with a history of hypertensive disorders of pregnancy, for example, may carry a different long-term risk profile than one without that history. Menopause can also coincide with adverse changes in lipids, body composition, and vascular function. These are not niche considerations; they are part of routine cardiovascular prevention in adult women.
What makes these issues more difficult is that clinical research has not always matched the epidemiology. Women continue to be underrepresented in cardiovascular studies, and that imbalance can blur how well trial findings translate to everyday care. When research populations do not adequately reflect the patients seen in clinics, generalizations become less reliable. The answer is not conjecture. It is better evidence, more inclusive enrollment, and stronger attention to sex-specific outcomes.
Go Red for Women has operated since 2004 with that agenda in mind. The movement is built around awareness, but its deeper purpose is to shift how women understand and manage cardiovascular risk. The national effort is sponsored by CVS Health, while the Central Kentucky movement also draws local support from CommonSpirit Health, Gratz Park Private Wealth, and Sutherland & Associates. The funding structure matters because prevention campaigns need durable backing if they are to reach beyond a single event and into routine care.
A public health message aimed at earlier action
The language around the event returns again and again to the same point: women should not wait to act on heart health. That is a reasonable clinical message because delays compound risk. Silent hypertension, untreated hyperlipidemia, diabetes, and poorly recognized warning signs can move patients from low-risk to high-risk status before they ever enter a cardiology clinic.
At the population level, campaigns like this one try to reduce that delay by changing knowledge, social support, and expectations. At the patient level, the payoff would be earlier screening and faster treatment. At the clinician level, the stakes are more specific: remember that female cardiovascular risk is shaped by biology, reproductive history, and unequal access to emergency response, and do not let those features be treated as secondary details.
The event’s fundraising total is concrete, but the larger clinical test lies ahead. Whether awareness efforts translate into sustained improvements in prevention, diagnosis, and emergency response for women in Central Kentucky will depend on how effectively those dollars are turned into care, education, and research that reaches the bedside.